Hims & Hers Q2 revenue up 83% to $207.9M; raises FY 2023 guidance

Hims & Hers Health, Inc.

2023-Q2 EPS reported -$0.08 revenue$398,682,000

Revenue $207.9M, up 83% YoY; net loss narrowed to $7.2M from $19.7M.
Adjusted EBITDA turned positive at $10.6M versus -$7.5M in Q2 2022.
Subscribers grew 74% to 1.3M; monthly online revenue per subscriber $53.
Raised FY 2023 revenue guidance to $830-850M and Adjusted EBITDA to $35-40M.
Expanded into Cardiovascular Health and Weight Management categories.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Hims & Hers Health, Inc. reported the quarter ended June 30, 2023 results: revenue $207.9 million, net income $(7.2) million. Guidance raised.

Period: the quarter ended June 30, 2023
Revenue: $207.9 million
Net income: $(7.2) million
Guidance: raised
Result: reported results

Exact text from the filing

reference in such a filing. --- EX-99.1 (EX-99.1) --- Hims & Hers Health, Inc. Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Outlook Revenue of $207.9 million, up 83% year-over-year in Q2 2023 Net loss of $7.2 million; Adjusted EBITDA profitability of $10.6 million in Q2 2023 Subscribers grew to 1.3 million, up 74% year-over-year in Q2

View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

Hims & Hers Health, Inc. filing history →

Source: SEC EDGAR

accession 0001773751-23-000204

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.